ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,265,261 | +41.7% | 237,619 | +60.4% | 0.02% | +50.0% |
| Q2 2023 | $3,009,312 | +12.9% | 148,169 | +1.4% | 0.01% | +11.1% |
| Q1 2023 | $2,665,429 | -12.0% | 146,131 | -0.2% | 0.01% | -18.2% |
| Q4 2022 | $3,028,607 | -60.7% | 146,451 | -50.3% | 0.01% | -26.7% |
| Q3 2022 | $7,708,310 | -20.5% | 294,672 | -23.0% | 0.02% | -16.7% |
| Q2 2022 | $9,700,329 | +14.3% | 382,820 | +42.3% | 0.02% | +50.0% |
| Q1 2022 | $8,490,293 | +56.0% | 269,030 | +100.0% | 0.01% | -14.3% |
| Q4 2021 | $5,444,000 | – | 134,515 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |